Higher-cost medicines drove 14.1 per cent spike in patented drug prices: Report
The Patented Medicine Prices Review Board has published its latest report, finding that “drug costs jumped by 14.1 per cent in 2023, rebounding from three years of moderate increases of four...To view the full article, register now.
Already a subscriber? Click here to view full article